STOCK TITAN

ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Canaccord Genuity 43rd Annual Growth Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
ImmunoGen to participate in fireside chat at Canaccord Genuity Annual Growth Conference
Positive
  • Participation in Canaccord Genuity conference could positively impact stock price
Negative
  • No negative takes

WALTHAM, Mass.--(BUSINESS WIRE)-- ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will participate in a fireside chat at the upcoming Canaccord Genuity 43rd Annual Growth Conference in Boston, MA. The presentation is scheduled for August 10, 2023 at 10:00 am ET.

A webcast of the presentation will be accessible through the “Investors and Media” section of the Company’s website, www.immunogen.com. Following the live webcast, a replay will be available at the same location.

ABOUT IMMUNOGEN

ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to TARGET A BETTER NOW™.

Learn more about who we are, what we do, and how we do it at www.immunogen.com.

INVESTOR RELATIONS CONTACT

ImmunoGen

Anabel Chan

781-895-0600

anabel.chan@immunogen.com

MEDIA CONTACTS

ImmunoGen

Courtney O'Konek

781-895-0600

courtney.okonek@immunogen.com

OR

FTI Consulting

Robert Stanislaro

212-850-5657

robert.stanislaro@fticonsulting.com

Source: ImmunoGen, Inc.

FAQ

When is the Canaccord Genuity Annual Growth Conference?

The conference is scheduled for August 10, 2023 at 10:00 am ET.

Where can I access the webcast of the presentation?

The webcast will be accessible through the 'Investors and Media' section of ImmunoGen's website.

Will there be a replay of the presentation available?

Yes, a replay will be available at the same location after the live webcast.

ImmunoGen, Inc.

NASDAQ:IMGN

IMGN Rankings

IMGN Latest News

IMGN Stock Data

8.72B
247.85M
0.32%
86.52%
7.38%
Biotechnology
Healthcare
Link
United States
Waltham